What to combine L-tyrosine with

L-tyrosine is rarely taken in isolation: it is part of pre-workout blends, "nootropic" stacks and complexes for concentration. However, not every combination has a scientific basis, and some may be undesirable. The editors examined which substances tyrosine combines with logically, which neutrally, and which are better avoided.

The principle: what determines whether a combination makes sense

To evaluate any combination with tyrosine, it is worth recalling three facts. First: tyrosine is the raw material for the synthesis of dopamine and noradrenaline, but it does not itself release these mediators or block their breakdown. Second: it enters the brain via the large neutral amino acid transporter, for which other amino acids compete. Third: the most noticeable effect of tyrosine is observed when the catecholamine systems are working "at the limit" — under stress, with sleep deprivation, during difficult tasks.

From this follow logical rules. Combinations with substances that act by a different mechanism (for example, blocking adenosine receptors, like caffeine) can theoretically complement each other. Combinations with substances that compete for the same transport can weaken the effect. And combinations with strong sympathomimetics can amplify not only the desired but also the side effects.

It is also important that there are very few studies of specific "stacks" with tyrosine. Most recommendations online are based on mechanistic reasoning rather than clinical trials of combinations. In this article the editors clearly distinguish where there is data and where there is only theory.

Finally, an effective combination makes no sense if the tyrosine in it is dosed only symbolically. In many complexes its amount is far smaller than what was tested in studies, so one should not expect "synergy" from such a product.

Caffeine and L-theanine

Caffeine is the most common partner of tyrosine in pre-workouts. The mechanisms differ: caffeine blocks adenosine receptors and thereby indirectly enhances dopaminergic transmission, while tyrosine provides the raw material for mediator synthesis. In theory this complement looks reasonable, especially under sleep deprivation.

However, there are few direct high-quality studies of the "caffeine + tyrosine" pair specifically, and they do not provide grounds to speak of proven synergy. The ergogenic action of caffeine is well substantiated on its own and described in the position paper of the International Society of Sports Nutrition (Guest et al., 2021); the contribution of tyrosine to such a combination remains undefined.

The practical risk of the pair lies in stimulation. If caffeine already causes you tremor, tachycardia or insomnia, adding tyrosine is unlikely to improve tolerability. People sensitive to stimulants should first assess their reaction to each component separately.

L-theanine is an amino acid from tea, often added to "smooth out" the effect of caffeine. The combination of caffeine with theanine has its own evidence base regarding attention (Owen et al., 2008). Tyrosine fits into this pair without an obvious conflict of mechanisms, but the editors did not find studies of the three-component combination.

Carbohydrates, protein and timing

Carbohydrates are the only partner of tyrosine that has been directly tested in a sports study. Chinevere and colleagues (2002) compared tyrosine, carbohydrates, their combination and placebo during prolonged cycling. Carbohydrates improved the result, while adding tyrosine to carbohydrates provided no additional advantage.

The practical conclusion: during prolonged exercise the main ergogenic contribution is made by carbohydrate nutrition, while tyrosine in a sports drink is more of an addition without a proven effect. Combining them is not harmful, but relying on tyrosine is not worthwhile.

With protein the situation is the opposite. A high-protein meal simultaneously raises the concentration of many large neutral amino acids that compete with tyrosine for transport into the brain. That is why in studies tyrosine was usually given separately from main meals — on an empty stomach or with a light snack, roughly 30–60 minutes before a stressful load.

This does not mean you cannot eat protein after the supplement. It only means that mixing a single dose of tyrosine with a large portion of a protein shake is not the best idea if the goal is specifically a cognitive effect.

Cofactors: iron, vitamins B6 and C

The enzymes that convert tyrosine into catecholamines require cofactors. Tyrosine hydroxylase needs iron and tetrahydrobiopterin, aromatic amino acid decarboxylase needs the active form of vitamin B6, and dopamine β-hydroxylase needs vitamin C and copper. That is why in "dopamine" complexes tyrosine is often combined with B vitamins and vitamin C.

Such a combination makes sense only when a person truly has a deficiency. Iron deficiency, for example, is common among female athletes and long-distance runners and is associated with fatigue; it should be confirmed by tests (ferritin, hemoglobin) and corrected under a doctor’s supervision.

If cofactors are sufficient, additional vitamins do not speed up catecholamine synthesis: the enzymes already work with a full set of "tools." So megadoses of B6 or vitamin C in a complex are marketing, not pharmacology. Long-term intake of high doses of B6 can moreover cause peripheral neuropathy.

The sensible approach is to provide cofactors through the diet or, if necessary, an ordinary multivitamin, rather than seeking "special" tyrosine formulas with excessive doses.

Combinations to avoid

The first group is prescription drugs that affect catecholamines. MAO inhibitors (including selegiline and rasagiline) and levodopa are combinations that require a doctor’s decision. The same applies to ADHD medications.

The second group is strong sympathomimetics in "fat burners": synephrine, yohimbine, ephedra derivatives (which in many countries are banned in supplements). Combined with caffeine and tyrosine, they create a cumulative load on the cardiovascular system, and the benefit of tyrosine in such a formula is imperceptible against the background of the stimulants.

The third group is the serotonin precursor 5-HTP. Both substances are converted by the same enzyme — aromatic amino acid decarboxylase — and in popular "balancing" schemes they are combined for "equilibrium" of mediators. There is no clinical evidence of the effectiveness and safety of such combinations.

• Do not combine tyrosine with MAOIs, levodopa and thyroid drugs without a doctor.
• Avoid formulas that combine tyrosine with several stimulants at once.
• Do not build your own "neurotransmitter stacks" from 5-HTP and tyrosine.

Editorial conclusions

Most logically, tyrosine combines with caffeine and theanine, but there is no proven synergy; these are acceptable but not mandatory combinations. For endurance, the main role is played by carbohydrates, not tyrosine.

The cofactors of catecholamine synthesis matter only in case of deficiency, and a large protein meal taken together with the supplement can reduce its effect.

Strong stimulants, drugs that affect catecholamines, and homemade "stacks" with 5-HTP are combinations the editors advise against.

Related topics on our blog: "Myths about L-tyrosine," "5-HTP: what it is and how it works" and "Who should not take L-tyrosine."

References

1. Fernstrom JD, Fernstrom MH. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J Nutr. 2007;137(6 Suppl 1):1539S–1547S.
2. Chinevere TD, Sawyer RD, Creer AR, et al. Effects of L-tyrosine and carbohydrate ingestion on endurance exercise performance. J Appl Physiol. 2002;93(5):1590–1597.
3. Guest NS, VanDusseldorp TA, Nelson MT, et al. International Society of Sports Nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr. 2021;18(1):1.
4. Owen GN, Parnell H, De Bruin EA, Rycroft JA. The combined effects of L-theanine and caffeine on cognitive performance and mood. Nutr Neurosci. 2008;11(4):193–198.
5. Jongkees BJ, Hommel B, Kühn S, Colzato LS. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands — a review. J Psychiatr Res. 2015;70:50–57.
6. Nutt JG, Woodward WR, Hammerstad JP, et al. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med. 1984;310(8):483–488.